[THE REDUCTION OF RADIOPHOSPHORUS 32 INCORPORATION INTO CANCER CELLS BY NONTOXIC DOSES OF CYTOSTATIC SUBSTANCES].
D000818:Animals; D002277:Carcinoma; D002286:Carcinoma, Ehrlich Tumor; D003520:Cyclophosphamide; D054697:Cytostatic Agents; D008357:Mannomustine; D008466:Mechlorethamine; D008558:Melphalan; D008660:Metabolism; D051379:Mice; D009369:Neoplasms; D009374:Neoplasms, Experimental; D009588:Nitrogen Mustard Compounds; D010759:Phosphorus Isotopes; D011832:Radiation Injuries; D011833:Radiation Injuries, Experimental; D012106:Research; D014265:Triethylenemelamine
D054697:Cytostatic Agents; D009588:Nitrogen Mustard Compounds; D010759:Phosphorus Isotopes; D008466:Mechlorethamine; D003520:Cyclophosphamide; D008357:Mannomustine; D014265:Triethylenemelamine; D008558:Melphalan
CARCINOMA, EHRLICH TUMOR; CYCLOPHOSPHAMIDE; EXPERIMENTAL LAB STUDY; MANNOMUSTINE; MECHLORETHAMINE OXIDE; MELPHALAN; METABOLISM; MICE; NEOPLASMS, EXPERIMENTAL; NITROGEN MUSTARD COMPOUNDS; PHOSPHORUS ISOTOPES; RADIATION INJURY, EXPERIMENTAL; TRIETHYLENE MELAMINE
DIE VERMINDERUNG DES RADIOPHOSPHOR 32-EINBAUES IN DIE KARZINOMZELLEN DURCH NICHT TOXISCHE DOSEN VON ZYTOSTATISCHEN SUBSTANZEN.